Isthmus Partners’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.6M | Buy |
148,235
+2,615
| +2% | +$229K | 1.31% | 27 |
|
|
2026
Q1 | $12.4M | Buy |
145,620
+5,273
| +4% | +$470K | 1.3% | 31 |
|
|
2025
Q4 | $11.1M | Buy |
140,347
+932
| +0.7% | +$73.1K | 1.23% | 32 |
|
|
2025
Q3 | $11.1K | Buy |
139,415
+1,996
| +1% | +$170K | ﹤0.01% | 139 |
|
|
2025
Q2 | $12.5M | Buy |
137,419
+308
| +0.2% | +$28.1K | 1.46% | 29 |
|
|
2025
Q1 | $12.8M | Buy |
137,111
+2,354
| +2% | +$211K | 1.61% | 21 |
|
|
2024
Q4 | $12.3M | Sell |
134,757
-197
| -0.1% | -$18.8K | 1.49% | 26 |
|
|
2024
Q3 | $14M | Sell |
134,954
-1,063
| -0.8% | -$108K | 1.66% | 22 |
|
|
2024
Q2 | $13.2M | Sell |
136,017
-1,367
| -1% | -$126K | 1.55% | 16 |
|
|
2024
Q1 | $12.4M | Buy |
137,384
+25
| +0% | +$2.12K | 1.4% | 28 |
|
|
2023
Q4 | $10.9M | Buy |
137,359
+4,718
| +4% | +$355K | 1.42% | 33 |
|
|
2023
Q3 | $9.43M | Buy |
132,641
+512
| +0.4% | +$38.3K | 1.36% | 33 |
|
|
2023
Q2 | $10.2M | Buy |
132,129
+970
| +0.7% | +$75.1K | 1.39% | 32 |
|
|
2023
Q1 | $9.86M | Buy |
131,159
+3,304
| +3% | +$246K | 1.39% | 31 |
|
|
2022
Q4 | $10.1M | Sell |
127,855
-1,202
| -0.9% | -$90.1K | 1.51% | 23 |
|
|
2022
Q3 | $9.07M | Buy |
129,057
+683
| +0.5% | +$53.6K | 1.56% | 21 |
|
|
2022
Q2 | $10.3M | Buy |
128,374
+1,465
| +1% | +$115K | 1.92% | 14 |
|
|
2022
Q1 | $9.62M | Buy |
126,909
+6,421
| +5% | +$509K | 1.58% | 30 |
|
|
2021
Q4 | $10.3M | Buy |
120,488
+1,449
| +1% | +$113K | 1.72% | 21 |
|
|
2021
Q3 | $9M | Buy |
119,039
+1,144
| +1% | +$90.8K | 1.63% | 24 |
|
|
2021
Q2 | $9.59M | Sell |
117,895
-1,326
| -1% | -$108K | 1.69% | 21 |
|
|
2021
Q1 | $9.4M | Buy |
+119,221
| New | +$9.34M | 1.73% | 23 |
|
|
2019
Q2 | – | Sell |
-72,504
| Closed | -$1.27M | – | 150 |
|
|
2019
Q1 | $1.27M | Buy |
+72,504
| New | +$4.68M | 0.31% | 61 |
|
|
2018
Q4 | – | Sell |
-260
| Closed | -$17K | – | 161 |
|
|
2018
Q3 | $17K | Hold |
260
| – | – | ﹤0.01% | 230 |
|
|
2018
Q2 | $17K | Hold |
260
| – | – | ﹤0.01% | 218 |
|
|
2018
Q1 | $19K | Hold |
260
| – | – | 0.01% | 212 |
|
|
2017
Q4 | $20K | Hold |
260
| – | – | 0.01% | 209 |
|
|
2017
Q3 | $19K | Hold |
260
| – | – | 0.01% | 214 |
|
|
2017
Q2 | $19K | Hold |
260
| – | – | 0.01% | 223 |
|
|
2017
Q1 | $19K | Buy |
+260
| New | +$18.2K | 0.01% | 223 |
|
Other funds holding CL
Isthmus Partners's CL Position: Q2 2026 in Review
Isthmus Partners increased its Colgate-Palmolive (CL) stake by 1.8% in Q2 2026, buying an estimated $229K and bringing the position to 148,235 shares worth $13.6M. The position accounts for 1.31% of the portfolio, ranked #27.
Isthmus Partners first reported a position in CL in Q1 2017 and has held it in 30 quarters since. The position peaked at $14M in Q3 2024. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Isthmus Partners held 148,235 shares of Colgate-Palmolive worth $13.6M as of Q2 2026.
- Isthmus Partners bought 2,615 Colgate-Palmolive shares in Q2 2026, an estimated $229K.
- Colgate-Palmolive made up 1.31% of Isthmus Partners's portfolio in Q2 2026, its #27 holding.
- Isthmus Partners first reported a position in Colgate-Palmolive in Q1 2017 and has held it in 30 quarters since.
- Isthmus Partners's Colgate-Palmolive position peaked at $14M in Q3 2024.
- 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Isthmus Partners's 13F filing for Q2 2026, filed 20 Jul 2026.